HCA Healthcare Inc.
HCA | NYSE
$425.97
-$1.74 (-0.41%)
At close: Sep 21, 2026, 4:00 PM ET
$425.97
$0 (0.00%)
After-hours:
Sep 21, 2026, 5:55 PM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 75.6B | 70.6B | 64.97B | 60.23B | 58.75B | 51.53B |
Cost of Revenue | 44.23B | 41.93B | 39.39B | 37.06B | 36.26B | 8.37B |
Gross Profit | 31.37B | 28.68B | 25.58B | 23.18B | 22.49B | 43.16B |
Operating Income | 11.97B | 10.55B | 9.63B | 9.05B | 9.68B | 7.26B |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | 9.83B | 8.52B | 7.71B | 8.58B | 9.83B | 5.43B |
Net Income | 6.78B | 5.76B | 5.24B | 5.64B | 6.96B | 3.75B |
Selling & General & Admin | 8B | 31.17B | 29.49B | 27.69B | 26.78B | 23.87B |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | 11.41B | -13.04B | -13.54B | -13.56B | -13.97B | 12.03B |
Operating Expenses | 19.41B | 18.13B | 15.95B | 14.12B | 12.81B | 35.9B |
Interest Expense | 2.25B | 2.06B | 1.94B | 1.74B | 1.53B | 1.56B |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 63.64B | 60.06B | 55.34B | 51.18B | 49.07B | 44.27B |
Income Tax Expense | 2.05B | 1.87B | 1.62B | 1.75B | 2.11B | 1.04B |
Shares Outstanding (Basic) | 230.71M | 258.6M | 272.4M | 290.35M | 323.32M | 339.43M |
Shares Outstanding (Diluted) | 230.71M | 261.81M | 276.41M | 294.67M | 328.75M | 345.37M |
EPS (Basic) | 28.62 | 22.27 | 19.24 | 19.44 | 21.51 | 11.08 |
EPS (Diluted) | 28.38 | 22 | 18.96 | 19.15 | 21.16 | 10.93 |
EBITDA | 15.6B | 13.9B | 12.72B | 13.29B | 14.25B | 9.74B |
EBIT | 12.08B | 10.58B | 9.64B | 10.32B | 11.4B | 7.01B |
Depreciation & Amortization | 3.52B | 3.31B | 3.08B | 2.97B | 2.85B | 2.72B |
Add to Watchlist
Select watchlists to add or remove HCA